Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China

In China, HIV-1-infected patients typically receive antiretroviral therapy (ART) that includes lamivudine (3TC) as a reverse-transcriptase inhibitor (RTI) (ART-3TC). Previous studies from certain developed countries have shown that, in ART-3TC, 3TC-resistant HBV progressively emerges at an annual ra...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: Gu, Lijun, Han, Yang, Li, Yijia, Zhu, Ting, Song, Xiaojing, Huang, Ying, Yang, Feifei, Guan, Shuo, Xie, Jing, Gohda, Jin, Hosoya, Noriaki, Kawana-Tachikawa, Ai, Liu, Wenjun, Gao, George Fu, Iwamoto, Aikichi, Li, Taisheng, Ishida, Takaomi
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2015
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4543549/
https://ncbi.nlm.nih.gov/pubmed/26288093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0134539
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi